Scarica l'app Stockscreener
144.74
1.87%
-2.76
Dopo l'orario di chiusura:
144.91
0.17
+0.12%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GILD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Gilead Sciences Inc Borsa (GILD) Ultime notizie
Confluence Investment Management LLC Cuts Position in Gilead Sciences, Inc. $GILD - MarketBeat
More Upside Awaits for Gilead Sciences Stock. Stay Invested. - Barron's
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Gilead expands lenacapavir licenses: Gilead Sciences stock has 6.53 percent upside - AD HOC NEWS
Gilead Sciences stock pre-market at EUR 131.75: plus 0.54 percent - AD HOC NEWS
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors - Yahoo Finance
Gilead Sciences, Inc. (GILD) stock price, news, quote and history - uk.finance.yahoo.com
Gilead Sciences (NASDAQ:GILD) Stock: Stronger HIV Sales Meet Weaker Reported Earnings - kalkine.ca
Can Lenacapavir Power Gilead Sciences (GILD)’s Next Growth Phase? - Yahoo Finance
Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside? - Yahoo Finance
Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing? - Yahoo Finance
Can Gilead Sciences (GILD) Justify Its Price As It Raises 2026 Guidance And Dividend? - Yahoo Finance
Gilead Sciences (GILD) Share Price, News, Stock Market Cap NASDAQ - TechGraph
CEUX:GISd Dividend: Does Gilead Sciences Inc Pay a Dividend? - GuruFocus
Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income? - Insider Monkey
Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? - Yahoo Finance
Gilead or Johnson & Johnson: Is Faster Growth Better than Greater Diversification? - Yahoo Finance
Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own? - Insider Monkey
Form 4 Gilead Sciences Inc For: 26 September By Investing.com - Investing.com Nigeria
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Has Average Price Target of $158.78 According to Analysts - MarketBeat
Gilead Sciences stock closes at USD 149.69, down 1.11 percent at the close - AD HOC NEWS
UBS Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $175 - Moomoo
Gilead Sciences stock falls 1.11 percent despite revenue growth - AD HOC NEWS
Gilead Sciences, Inc. $GILD Stake Decreased by Envestnet Asset Management Inc. - MarketBeat
Gilead Sciences stock heads into the open after a 0.4 percent gain - AD HOC NEWS
Gilead Sciences Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Form DEF 14A Gilead Sciences Inc For: 24 September By Investing.com - Investing.com Canada
Gilead Sciences stock slips 0.85 percent ahead of the open - AD HOC NEWS
Gilead: HIV Growth Is Not Enough At The Current Price (NASDAQ:GILD) - Seeking Alpha
Gilead Sciences stock slips 1.30 percent at the close - AD HOC NEWS
Gilead Sciences, Inc. (GILD) latest stock news and headlines - Yahoo Finance Singapore
Gilead Sciences stock slips as earnings estimates shift - AD HOC NEWS
Can Gilead Sciences (NASDAQ:GILD) turn HIV leadership and oncology development into a stronger market story? - Kalkine Media
Gilead Sciences, Inc. (GILD) Stock Price, News, Quote & History - Yahoo! Finance Canada
Gilead Sciences stock slips 0.7 percent ahead of the open - AD HOC NEWS
Gilead Sciences Research Scholars Program in Solid Tumors – US 2026 - Oncodaily
Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH - The Motley Fool
Gilead Sciences (GILD) Stock Moves 1.40%: What You Should Know - Yahoo Finance
Gilead Sciences stock slips 0.7 percent at the close - AD HOC NEWS
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch
Andra AP fonden Sells 11,400 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences FY2026 EPS Increased by Erste Group Bank - MarketBeat
THNR's Weight-Loss Index Swaps Hims & Hers for Gilead - ETF Database
Here's How Much $1000 Invested In Gilead Sciences 5 Years Ago Would Be Worth Today - Benzinga
Gilead Sciences stock holds near 52-week high as HIV prevention deal and analyst optimism support va - AD HOC NEWS
Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring Revenue Growth and Strategic Collaborations - DirectorsTalk Interviews
Erste Group Bank Estimates Gilead Sciences FY2027 Earnings - MarketBeat
Gilead Sciences stock heads into the open after a 0.52% dip - ad-hoc-news.de
Gilead Sciences stock gains as HIV drug access expands - AD HOC NEWS
Why Morgan Stanley likes Gilead’s HIV prevention play - thestreet.com
Why Is Gilead Sciences (GILD) Widening Lenacapavir Access Across 120 Countries? - Yahoo Finance
Gilead Sciences (NASDAQ:GILD) Upgraded to Buy at Wall Street Zen - MarketBeat
Why Is Gilead Sciences (NASDAQ:GILD) in Focus Across S&P 500? - Kalkine Media
Nykredit A S Invests $140.59 Million in Gilead Sciences, Inc. $GILD - MarketBeat
[Press releases] Gilead Sciences provides updates on access to lenacapavir for HIV prevention - European AIDS Treatment Group
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know - Yahoo Finance
Gilead Sciences (GILD) CFO Andrew Dickinson Sells 3,000 Shares a - GuruFocus
After $435,870 sale, Gilead (NASDAQ: GILD) CFO still holds 164K shares - Stock Titan
Gilead (NASDAQ: GILD) exec sells 3,000 shares in pre-arranged trades - Stock Titan
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):